https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html
Moderna:
>After carrying out a Phase 2 study they launched a Phase 3 trial on July 27. The final trial [the July 27 one] will enroll 30,000 healthy people at about 89 sites around the United States. On August 11, the government awarded the company an additional $1.5 billion in exchange for 100 million doses if the vaccine proves safe and effective.
Pfizer:
On July 27, the companies announced the launch of a Phase 2/3 trial with 30,000 volunteers in the United States and other countries including Argentina, Brazil, and Germany.
Oxford University:
>A vaccine in development by the British-Swedish company AstraZeneca and the University of Oxford is based on a chimpanzee adenovirus called ChAdOx1. A study on monkeys found that the vaccine provided them protection. In May, the United States awarded the project $1.2 billion in support. Their Phase 1/2 trial revealed that the vaccine was safe, causing no severe side effects. It raised antibodies against the coronavirus as well as other immune defenses. The vaccine is now in Phase 2/3 trials in England and India, as well as Phase 3 trials in Brazil and South Africa.
>If these large-scale trials yield positive results, AstraZeneca has indicated they could deliver emergency vaccines as soon as October. The company has said their total manufacturing capacity for the vaccine, if approved, stands at two billion doses.
Why is this the first that I've heard of this? Why isn't this front page news?
Moderna:
>After carrying out a Phase 2 study they launched a Phase 3 trial on July 27. The final trial [the July 27 one] will enroll 30,000 healthy people at about 89 sites around the United States. On August 11, the government awarded the company an additional $1.5 billion in exchange for 100 million doses if the vaccine proves safe and effective.
Pfizer:
On July 27, the companies announced the launch of a Phase 2/3 trial with 30,000 volunteers in the United States and other countries including Argentina, Brazil, and Germany.
Oxford University:
>A vaccine in development by the British-Swedish company AstraZeneca and the University of Oxford is based on a chimpanzee adenovirus called ChAdOx1. A study on monkeys found that the vaccine provided them protection. In May, the United States awarded the project $1.2 billion in support. Their Phase 1/2 trial revealed that the vaccine was safe, causing no severe side effects. It raised antibodies against the coronavirus as well as other immune defenses. The vaccine is now in Phase 2/3 trials in England and India, as well as Phase 3 trials in Brazil and South Africa.
>If these large-scale trials yield positive results, AstraZeneca has indicated they could deliver emergency vaccines as soon as October. The company has said their total manufacturing capacity for the vaccine, if approved, stands at two billion doses.
Why is this the first that I've heard of this? Why isn't this front page news?
